CANOPY-N: A Phase 2 Study of Canakinumab or Pembrolizumab, Alone or in Combination, as Neoadjuvant Therapy in Patients With Resectable, Stage IB–IIIA NSCLC by Jay M. Lee, MD, Jean-Louis Pujol, MD, PhD, Jun Zhang, MD, PhD, Oleg Leonov, MD, PhD, Masahiro Tsuboi, MD, PhD, Edward S. Kim, MD, MBA, Calvin Ng, MD, Nicolas Moreno-Mata, MD, PhD, Amy Cummings, MD, PhD, Ilhan Hacibekiroglu, MD, Abidin Sehitogullari, MD, Nirmal Veeramachaneni, MD, Cathy Spillane, PhD, Jiawei Duan, PhD, Claudia Bossen, PhD, Alexander Savchenko, MD, PhD, Chiara Lobetti-Bodoni, MD, PhD, Tony Mok, MD, Pilar Garrido, MD

Get full text

Longitudinal Analyses and Predictive Factors of Radiation-Induced Lymphopenia After Postmastectomy Hypofractionated Radiation Therapy for Breast Cancer: A Pooled Cohort Study of 2... by Xu-Ran Zhao, MD, Hui Fang, MD, Hao Jing, MD, Qiu-Zi Zhong, MD, Hong-Fen Wu, MD, Xiao-Rong Hou, MD, Li-Hua Dong, MD, Ya-Hua Zhong, MD, Jing Jin, MD, Li-Na Zhao, MD, Xiao-Hong Wang, MD, Wei-Fang Yang, MD, Jian Tie, MD, Yu-Fei Lu, MD, Guang-Yi Sun, MD, Dan-Qiong Wang, MD, Yu Tang, MD, Shu-Nan Qi, MD, Yong-Wen Song, MD, Yue-Ping Liu, MD, Yuan Tang, MD, Ning-Ning Lu, MD, Bo Chen, MD, Wen-Wen Zhang, MD, Yi-Rui Zhai, MD, Shang-Ying Hu, Jun Zhang, MD, Ye-Xiong Li, MD, Na Zhang, MD, Shu-Lian Wang, MD

Get full text